REMS Take Effect; FDA Identifies 16 Products With RiskMAPs That Qualify
Executive Summary
Manufacturers of approved products whose marketing conditions qualify for a Risk Evaluation and Mitigation Strategy will have to develop a timeline for the assessment of their risk management efforts by September 21
You may also be interested in...
REMS In The Slow Lane: Majority Of "Deemed" Products Still Not "Converted"
But FDA says it hopes that several will be switched within the next few months.
REMS Assessments Need Very Recent Data, FDA Draft Guidance Says
Sponsors conducting assessments of a product's Risk Evaluation and Mitigation Strategy will need to complete them within 60 days of collecting the last piece of data, according to a draft FDA guidance
REMS Assessments Need Very Recent Data, FDA Draft Guidance Says
Sponsors conducting assessments of a product's Risk Evaluation and Mitigation Strategy will need to complete them within 60 days of collecting the last piece of data, according to a draft FDA guidance